David Heaney Acquires 8,874 Shares of Cyclopharm Limited (ASX:CYC) Stock

Cyclopharm Limited (ASX:CYC) insider David Heaney bought 8,874 shares of Cyclopharm stock in a transaction dated Wednesday, February 26th. The stock was acquired at an average price of A$1.50 ($0.93) per share, with a total value of A$13,266.63 ($8,240.14).

Cyclopharm Stock Performance

The stock has a market cap of $219.50 million, a price-to-earnings ratio of -20.32 and a beta of 0.70. The company has a debt-to-equity ratio of 11.72, a current ratio of 4.38 and a quick ratio of 4.68.

Cyclopharm Company Profile

Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. The company operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism.